Top

Published in:

01-09-2012 | Laboratory Investigation

IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma

Authors: Ying Liu, Wenqing Jiang, Jing Liu, Shimin Zhao, Ji Xiong, Ying Mao, Yin Wang

Published in: Journal of Neuro-Oncology | Issue 2/2012

Abstract

The mechanism of tumorigenesis associated with nicotinamide adenine dinucleotide phosphate (NADP⁺)-dependent isocitrate dehydrogenase 1 (IDH1) mutations in gliomas is not fully understood. Loss of catalytic activity leading to a decrease in α-ketoglutarate (αKG) and gain of novel catalytic activity leading to production of d-2-hydroxylglutarate (d-2-HG) are both found in IDH1-mutated glioma cells. Both the decrease of αKG and accumulation of d-2-HG inhibit the activity of multiple dioxygenases including prolyl hydroxylase domain-2 (PHD2), collagen prolyl-4-hydroxylase, histone demethylases, and the ten–eleven translocation (TET) family of 5-methylcytosine hydroxylases. Here we correlated the products of these dioxygenases after IDH1 gene mutations with tumorigenesis in human astroglioma samples. DNA sequencing was carried out for 253 astroglioma samples to identify IDH1 mutations. Immunohistochemistry analysis was employed to verify the levels of endostatin, dimethylated H3k79 (H3k79me2), and 5-hydroxymethylcytosine (5hmC) in these astroglioma samples. IDH1 mutations occurred frequently in low grades of astrocytoma. One case bearing both IDH1 and IDH2 mutations was identified. IDH1-mutated cases displayed more frontal lobe location and p53-positive immunostaining than wild-type cases. IDH1 mutations were associated with increased histone methylation and decreased 5hmC. By inhibiting endostatin expression, IDH1 mutations indirectly promoted angiogenesis in gliomas. All these changes were same in astroglioma at different malignancy grade. IDH1 mutations showed wide regulation of angiogenesis and genome-wide change of histone and DNA methylation, which were not suppressed as the malignancy level progressed, suggesting an early role of IDH1 mutations in astrocytoma tumorigenesis.

Available only for authorised users

Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812. doi:10.1126 PubMedCrossRef

Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773. doi:10.1056/NEJMoa0808710 PubMedCrossRef

Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, Rabinowitz JD, Carroll M, Su SM, Sharp KA, Levine RL, Thompson CB (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17:225–234. doi:10.1016/jccr201001020 PubMedCrossRef

Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Seo SI, Lee JY, Yoo NJ, Lee SH (2009) Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 125:353–355. doi:10.1002/ijc.24379 PubMedCrossRef

Hartong DT, Dange M, McGee TL, Berson EL, Dryja TP, Colman RF (2008) Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. Nat Genet 40:1230–1234. doi:10.1038/ng.223 PubMedCrossRef

Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, Ding J, Lei Q, Guan KL, Xiong Y (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261–265. doi:10.1126/science.1170944 PubMedCrossRef

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739–744. doi:10.1038/nature08617 PubMedCrossRef

Rzem R, Veiga-da-Cunha M, Noël G, Goffette S, Nassogne MC, Tabarki B, Schöller C, Marquardt T, Vikkula M, Van Schaftingen E (2004) A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101:16849–16854. doi:10.1073/pnas.0404840101 PubMedCrossRef

Topçu M, Jobard F, Halliez S, Coskun T, Yalçinkayal C, Gerceker FO, Wanders RJ, Prud’homme JF, Lathrop M, Ozguc M, Fischer J (2004) L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13:2803–2811. doi:10.1093/hmg/ddh300 PubMedCrossRef

10.

Aghili M, Zahedi F, Rafiee E (2009) Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review. J Neurooncol 91:233–236. doi:10.1007/s11060-008-9706-2 PubMedCrossRef

11.

Annunen P, Helaakoski T, Myllyharju J, Veijola J, Pihlajaniemi T, Kivirikko KI (1997) Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer. The alpha(I) and alpha(II) subunits do not form a mixed alpha(I)alpha(II) beta2 tetramer. J Biol Chem 272:17342–17348. doi:10.1074/jbc.272.28.17342 PubMedCrossRef

12.

Falnes PØ, Johansen RF, Seeberg E (2002) AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419:178–182. doi:10.1038/nature01048 PubMedCrossRef

13.

Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J (2003) Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278:30772–30780. doi:10.1074/jbc.M304982200 PubMedCrossRef

14.

Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J (2004) Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 279:9899–9904. doi:10.1074/jbc.M312254200 PubMed

15.

Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT, Liu LX, Jiang WQ, Liu J, Zhang JY, Wang B, Frye S, Zhang Y, Xu YH, Lei QY, Guan KL, Zhao SM, Xiong Y (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30. doi:10.1016/j.ccr.2010.12.014 PubMedCrossRef

16.

Kivirikko KI, Myllylä R, Pihlajaniemi T (1989) Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J 3:1609–1617. doi:10.1074/jbc.M312254200 PubMed

17.

O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285. doi:S0092-8674(00)81848-6 PubMedCrossRef

18.

Krane SM (2008) The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 35:703–710. doi:10.1007/s00726-008-0073-2 PubMedCrossRef

19.

Klose RJ, Kallin EM, Zhang Y (2006) JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet 7:715–727. doi:10.1038/nrg1945 PubMedCrossRef

20.

Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU, Xia X, Jesneck J, Bracken AP, Silverman LB, Kutok JL, Kung AL, Armstrong SA (2008) H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14:355–368. doi:10.1016/j.ccr.2008.10.001 PubMedCrossRef

21.

Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9:465–476. doi:10.1038/nrg2341 PubMedCrossRef

22.

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597–602. doi:10.1007/s00401-008-0455-2 PubMedCrossRef

23.

Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS (2011) Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29:4482–4490PubMedCrossRef

24.

Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297–310PubMedCrossRef

25.

Morimoto T, Aoyagi M, Tamaki M, Yoshino Y, Hori H, Duan L, Yano T, Shibata M, Ohno K, Hirakawa K, Yamaguchi N (2002) Increased levels of tissue endostatin in human malignant gliomas. Clin Cancer Res 8:2933–2938 http://clincancerres.aacrjournals.org/content/8/9/2933.long

26.

Sakurai T, Kudo M (2011) Signaling pathways governing tumor angiogenesis. Oncology 81:24–29. doi:10.1159/000333256 PubMedCrossRef

27.

Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES (2006) A bivalent chromatin structure marks key developemtal genes in embryonic stem cells. Cell 125:315–326. doi:10.1016/j.cell.2006.02.041 PubMedCrossRef

28.

Zhu JK, Active DNA (2009) Demethylation mediated by DNA glucosylases. Annu Rev Genet 43:143–166. doi:10.1146/annurev-genet-102108-134205 PubMedCrossRef

29.

Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome intergrates intrinsic and environmental signals. Nat Genet suppl 33:245–254. http://dx.doi.org/10.1038/ng1089

30.

Ooi SK, Bestor TH (2008) The colorful history of active DNA demethylation. Cell 133:1145–1148. doi:10.1016/j.cell.2008.06.009 PubMedCrossRef

31.

Bonasio R, Tu S, Reinberg D (2010) Molecular dignals of epigenetic states. Science 330:612–616. doi:10.1126/science.1191078 PubMedCrossRef

32.

Feng J, Fan G (2009) The roles of DNA methylation in the central nervous system and neuropsychiatric disorders. Int Rev Neurobiol 89:67–84. doi:10.1016/S0074-7742(09)89004-1 PubMedCrossRef

Title: IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma
Authors: Ying Liu
Wenqing Jiang
Jing Liu
Shimin Zhao
Ji Xiong
Ying Mao
Yin Wang
Publication date: 01-09-2012
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2012
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-012-0914-4

At a glance: The STEP trials

Springer Medicine

IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors

Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis

E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model

Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery

Resection of gliomas in the cingulate gyrus: functional outcome and survival

Isthmin inhibits glioma growth through antiangiogenesis in vivo